For the quarter ending 2025-09-30, GTHP has $903K in assets. $6,549K in debts.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 87 | 185 | ||
| Trade receivables, net of allowance for credit losses of 2 and 1 at september 30, 2025 and december 31, 2024, respectively | 6 | 8 | ||
| Inventory, net of reserves of 818 at june 30, 2024 and december 31, 2024 | 583 | 595 | ||
| Other current assets | 123 | 23 | ||
| Total current assets | 799 | 811 | ||
| Property and equipment, net | 18 | 18 | ||
| Operating lease right-of-use assets, net of amortization | 69 | 94 | ||
| Other assets | 17 | 17 | ||
| Total non-current assets | 104 | 129 | ||
| Total assets | 903 | 940 | ||
| Long-term lease liability | - | 0 | ||
| Long-term notes payable | - | 35 | ||
| Long-term convertible debt | - | 0 | ||
| Long-term debt, related parties | - | 0 | ||
| Total long-term liabilities | 79 | 35 | ||
| Accounts payable | 2,382 | 2,255 | ||
| Short-term notes payable | - | 24 | ||
| Accounts payable, related parties | 29 | - | ||
| Derivative liability at fair value | - | 60 | ||
| Accrued liabilities | 952 | 1,117 | ||
| Deferred revenue | 689 | 679 | ||
| Current portion of lease liability | 76 | 104 | ||
| Short-term notes payable due to related parties | 0 | - | ||
| Current portion of long-term debt, related parties | 606 | - | ||
| Short-term notes payable due to related parties | - | 25 | ||
| Current portion of notes payable | 116 | - | ||
| Current portion of long-term debt, related parties | - | 525 | ||
| Short-term convertible debt, net of discounts | 411 | 421 | ||
| Short-term convertible debt in default | 1,130 | 1,130 | ||
| Accounts payable, related parties | - | 37 | ||
| Total current liabilities | 6,470 | 6,377 | ||
| Total liabilities | 6,549 | 6,412 | ||
| Preferred stock, value-Series CPreferred Shares | 0 | 0 | ||
| Preferred stock, value-Series COne Preferred Shares | 61 | 61 | ||
| Preferred stock, value-Series CTwo Preferred Shares | 0 | 0 | ||
| Preferred stock, value-Series DConvertible Preferred Shares | 18 | 32 | ||
| Preferred stock, value-Series EConvertible Preferred Shares | 284 | 834 | ||
| Preferred stock, value-Series FConvertible Preferred Shares | 817 | 817 | ||
| Preferred stock, value-Series FTwo Convertible Preferred Shares | 438 | 438 | ||
| Common stock, 0.001 par value 500,000 shares authorized, 83,599 and 65,131 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 3,469 | 3,465 | ||
| Additional paid-in capital | 145,212 | 144,041 | ||
| Treasury stock at cost | 132 | 132 | ||
| Accumulated deficit | -155,813 | -155,028 | ||
| Total stockholders' deficit | -5,646 | -5,472 | ||
| Total liabilities and stockholders' deficit | 903 | 940 | ||
GUIDED THERAPEUTICS INC (GTHP)
GUIDED THERAPEUTICS INC (GTHP)